Nexstim

About:

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation.

Twitter/X: nexstimoyj

Top Investors: EQT Life Sciences, Capricorn Partners, Ilmarinen Mutual Pension Insurance Company, Finnvera Venture Capital, Sitra

Description:

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder. The company was founded in 2000 and is headquartered in Helsinki, Southern Finland.

Total Funding Amount:

$37.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Helsinki, Southern Finland, Finland

Founded Date:

2000-01-01

Contact Email:

info(AT)nexstim.com

Founders:

Markku Lahdenpaa, Pekka Puolakka, Risto Ilmoniemi

Number of Employees:

11-50

Last Funding Date:

2024-06-27

IPO Status:

Public

Industries: